ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00243581
Recruitment Status : Completed
First Posted : October 24, 2005
Last Update Posted : October 31, 2005
Sponsor:
Information provided by:
SwedishAmerican Health System

Brief Summary:
The objective of this study is to evaluate the effect of the Ornish Program on cardiovascular disease as measured by the IMT of the common carotid artery, and to compare this effect to outcomes from patients participating in traditional cardiac rehabilitation.

Condition or disease Intervention/treatment Phase
a Myocardial Infarction Coronary Artery Bypass Graft Surgery Percutaneous Transluminal Coronary Angioplasty Stent Placement Behavioral: Dean Ornish Heart Disease Reversing Program Phase 4

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness
Study Start Date : August 2000
Study Completion Date : May 2005




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

Patients will be accepted into the study if they demonstrate one or more of the following within the previous 12 months: a myocardial infarction, coronary artery bypass graft surgery, or percutaneous transluminal coronary angioplasty, stent placement, or rotoblator procedures. Patients will also accepted if they have stable angina as determined by the Rose Questionnaire or pacemaker associated with one or more of the previously mentioned diagnoses. For the purposes of this study, myocardial infarction is defined as the presence of at least two of the following three criteria: continuous chest pain lasting at least 30 minutes; electrocardiogram changes expressing an evolving myocardial infarction (ST segment elevation or depression, evolving Q waves, or symmetric inversion of T waves); or elevated cardiac enzyme levels (at least twice the I levels).

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00243581


Sponsors and Collaborators
SwedishAmerican Health System
Investigators
Principal Investigator: Steven G. Aldana, Ph.D. SwedishAmerican Health System

ClinicalTrials.gov Identifier: NCT00243581     History of Changes
Other Study ID Numbers: SACCM Ornish Clinical Trial
First Posted: October 24, 2005    Key Record Dates
Last Update Posted: October 31, 2005
Last Verified: May 2005

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases